New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.
Patients with uveitis exhibited lower risk for TB with adalimumab therapy, though the risk was not completely eliminated.
Medical Device Network on MSN
YSPH reports saliva test shows promise for tuberculosis detection
Led by YSPH and partners at CIDEIM at Icesi University, the research team conducted the study in Cali, Colombia.
Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, per data from the World Health Organization. A person infected with the ...
Thousands of people in California are diagnosed with tuberculosis each year. Amazon Big Spring Sale 2026 is almost here: Shop ...
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) has expanded its GMP (good manufacturing practices) analytical laboratory in Middleton, Wisconsin. PPD ® Laboratories’ ...
Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "Latent TB Testing Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering. The report analyses the Latent TB Testing Market by ...
The new government TB dashboard is a step forward for transparency and accountability in South Africa's response to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results